Search Results

The Candela GentleLase GL Dermatology Laser is indicated for the following uses:

1. the Photocoagulation of Dermatological vascular lesions.
2. the removal of hair.

The Candela (Modified) GentleLase GL Laser utilizes an Alexandrite rod (crystal) which emits pulsed energy at 755 nanometers in the near infrared region. Energy from the laser is directed to the targeted area via an optical fiber/handpiece delivery system. The Dynamic Cooling Device functions to cool the skin prior to laser treatment, minimizing thermal damage to skin during laser treatment and reducing pain associated with laser treatment. The Candela GentleLase Lasers are designed with six major components:

1. High voltage power supply and modulator system
2. Optical laser head
3. Circulator system
4. Optical delivery system
5. Software control system
6. Dynamic cooling device
   The Candela GentleLase Lasers are equipped with safety interlock systems to protect patients and operators. Users of the device make selections from an onboard control panel to regulate operation during treatment.

Here's an analysis of the provided text regarding the Candela GentleLase GL Laser System's acceptance criteria and supporting study information:

It's important to note that the provided document is a 510(k) summary for premarket notification, not a full clinical study report. Therefore, specific details about acceptance criteria, detailed performance metrics, and in-depth study methodology are often summarized or not present in the same way they would be in a peer-reviewed publication or a comprehensive clinical report.

Acceptance Criteria and Reported Device Performance

The 510(k) summary does not explicitly list quantitative acceptance criteria in a table format with corresponding reported performance metrics. Instead, the "acceptance criteria" are implied by the claim of substantial equivalence to predicate devices. The primary 'performance' described is the ability to achieve the intended uses without unexpected safety issues, aligning with the predicate device's performance.

Study Details

1. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective):

   • Sample Size: Not specified in the provided text. The document simply states "A clinical trial demonstrated that the GentleLase Laser System removes unwanted hair..." without providing the number of participants or treatments.
   • Data Provenance: Not specified.
   • Retrospective/Prospective: Not specified, but likely prospective given it's a "clinical trial" to demonstrate safety and effectiveness for marketing approval.

2. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience):

   • Not specified. The document does not describe how the success or failure of hair removal or lesion photocoagulation was explicitly measured or by whom.

3. Adjudication method (e.g. 2+1, 3+1, none) for the test set:

   • Not specified.

4. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, if so, what was the effect size of how much human readers improve with AI vs without AI assistance:

   • No, an MRMC study was not done. This device is a laser system for dermatological treatment and hair removal, not an AI-assisted diagnostic tool. Therefore, the concept of "human readers improve with AI" is not applicable here.

5. If a standalone (i.e. algorithm only without human-in-the loop performance) was done:

   • Yes, in essence. The clinical trial likely evaluated the performance of the device itself (the laser system) in standalone operation, applied by a human operator, to achieve its intended effect (hair removal, lesion photocoagulation). There is no "algorithm" in the sense of a standalone AI system being evaluated here without human involvement. The device is the therapeutic and cosmetic tool.

6. The type of ground truth used (expert consensus, pathology, outcomes data, etc.):

   • The document does not explicitly state the "ground truth" method. For hair removal, ground truth would typically involve assessing the reduction in hair count or density over time, often through visual inspection, photography, or specific measurement techniques. For photocoagulation of vascular lesions, ground truth would relate to the reduction or clearance of the lesion, assessed clinically. It would fall under outcomes data or clinical assessment.

7. The sample size for the training set:

   • Not applicable. This device is a physical laser system, not a machine learning algorithm. Therefore, there is no "training set" in the context of AI model development.

8. How the ground truth for the training set was established:

   • Not applicable. As above, there is no "training set" for this type of device.

Ask a specific question about this device